IN THE WORLD: Colorectal cancer is the third most common cancer. In 2012, 1.4 million new cases have been diagnosed and it is estimated that the number of new cases per year will increase up to 2.4 million by 2035.
IN THE MEDITERRANEAN AREA: Colorectal cancer incidence rate in EU Mediterranean countries is one of the highest in the world. Even though in non-EU Mediterranean countries this rate is sensibly lower, it is expected to experience a sharp rise by the next twenty years.
According to the studies carried out in the EUROMED CANCER Network project, effective screening programmes and strategies for cancer control have been developed in EU Mediterranean countries, while in some cases non-EU countries lack good information and prevention systems.
Being part of the Colomed network means having access to a common platform which allows sharing information and data on colorectal cancer research and treatment.
You will be able to take part in technology transfer processes and technical and scientific staff exchanges, fellowships and information on the most important international scientific events.
COLOMED is a scientific project funded by the Italian Ministry of Health in 2016. It is a platform for the creation of a network of clinical and research centres in the Mediterranean area.
Its main objective is promoting the integration and the development of health policies and good communication practices to improve colorectal cancer prevention and treatment in Mediterranean countries.
Who can access to the reserved area?
Representatives of institutions and clinical and research centres, operating in the field of colorectal cancer and health policies in Mediterranean countries, in partnership with Colomed.
Login to access the reserved area. If you are not registered yet, you can do it now: